Cory Jubinville, PhD

Stock Analyst at LifeSci Capital

(4.59)
# 975
Out of 5,136 analysts
141
Total ratings
53%
Success rate
17.5%
Average return

Stocks Rated by Cory Jubinville, PhD

Prime Medicine
Oct 5, 2026
Reiterated: Buy
Price Target: $6
Current: $4.27
Upside: +40.52%
Tenaya Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $4
Current: $0.3492
Upside: +1,045.48%
Mereo BioPharma Group
Jan 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.3075
Upside: -
Sionna Therapeutics
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $60
Current: $3.33
Upside: +1,701.80%
Inhibikase Therapeutics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.52
Upside: +228.95%
Tectonic Therapeutic
Nov 18, 2025
Reiterated: Buy
Price Target: $88
Current: $21.14
Upside: +316.27%
Rocket Pharmaceuticals
Nov 7, 2025
Reiterated: Buy
Price Target: $9
Current: $2.30
Upside: n/a
Larimar Therapeutics
Nov 5, 2025
Reiterated: Buy
Price Target: $22
Current: $3.02
Upside: n/a
Tarsus Pharmaceuticals
Nov 5, 2025
Reiterated: Buy
Price Target: $85 → $84
Current: $80.28
Upside: n/a
Liquidia
Nov 3, 2025
Reiterated: Buy
Price Target: $54 → $67
Current: $57.41
Upside: n/a